1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma
(
- Contribution to journal › Article
- 2022
-
Mark
PD‐L1 Expression in Non‐Small Cell Lung Cancer Specimens : Association with Clinicopathological Factors and Molecular Alterations
(
- Contribution to journal › Article
- 2021
-
Mark
Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma
(
- Contribution to journal › Article
- 2014
-
Mark
Telomerase activity analyzed with trap in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.
(
- Contribution to journal › Article
- 2013
-
Mark
Liquid-based cytology using cytorich Red/Tripath is diagnostically equivalent to conventional smears for bronchial washings and brushings and reduces the cost.
(
- Contribution to journal › Article
- 2010
-
Mark
Comparison of Liquid-Based Cytology and Conventional Filter Preparations in Urine: A Possible Serious Pitfall
(
- Contribution to journal › Letter
-
Mark
Podoplanin Is a Useful Marker for Identifying Mesothelioma in Malignant Effusions
(
- Contribution to journal › Article
-
Mark
Possibility of Mixed Progenitor Cells in Sea Star Arm Regeneration
2010) In Journal of Experimental Zoology Part B: Molecular and Developmental Evolution 314B(6). p.457-468(
- Contribution to journal › Article
- 2008
-
Mark
Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay.
(
- Contribution to journal › Article
-
Mark
CK5/6 in effusions: no difference between mesothelioma and pulmonary and nonpulmonary adenocarcinoma.
(
- Contribution to journal › Article